Leber's Hereditary Optic Neuropathy (LHON) Clinical Trial
Official title:
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
This study is a multicentre, prospective, non-interventional post-authorisation safety study (PASS) of the clinical outcomes for patients with LHON treated with Raxone®. No medication will be provided as part of this study. Raxone® will be obtained through commercial channels.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02796274 -
Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)
|
||
Completed |
NCT02774005 -
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
|
Phase 4 | |
Recruiting |
NCT04912843 -
Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
|
Phase 2/Phase 3 | |
Terminated |
NCT01389817 -
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
|
Phase 1/Phase 2 | |
Completed |
NCT05555784 -
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection
|